Debt to Equity Ratio Chart

View Debt to Equity Ratio for ORXOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2004. Start Trial.
Date Value
March 31, 2026 0.0192
December 31, 2025 1.002
September 30, 2025 -2.190
June 30, 2025 -2.516
March 31, 2025 -3.00
December 31, 2024 -3.769
September 30, 2024 -17.63
June 30, 2024 19.96
March 31, 2024 8.502
December 31, 2023 8.044
September 30, 2023 5.202
June 30, 2023 4.177
March 31, 2023 4.106
December 31, 2022 2.783
September 30, 2022 1.816
June 30, 2022 1.762
March 31, 2022 1.660
December 31, 2021 1.575
September 30, 2021 1.343
June 30, 2021 1.207
March 31, 2021 1.035
December 31, 2020 0.521
September 30, 2020 0.464
June 30, 2020 0.3976
March 31, 2020 0.4178
Date Value
December 31, 2019 0.4874
September 30, 2019 0.5196
June 30, 2019 0.6947
March 31, 2019 0.7777
December 31, 2018 0.6734
September 30, 2018 0.7545
June 30, 2018 0.8851
March 31, 2018 1.046
December 31, 2017 0.9696
September 30, 2017 1.135
June 30, 2017 1.233
March 31, 2017 1.242
December 31, 2016 1.282
September 30, 2016 1.832
June 30, 2016 2.060
March 31, 2016 2.086
December 31, 2015 1.830
September 30, 2015 1.518
June 30, 2015 1.336
March 31, 2015 1.126
December 31, 2014 1.091
September 30, 2014 1.243
June 30, 2014 5.481
March 31, 2014 2.126
December 31, 2013 1.493

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Swedencare AB 0.253
Camurus AB 0.0249
Moberg Pharma AB 0.0032
Infant Bacterial Therapeutics AB 0.00
AstraZeneca PLC 0.7166